Riskpilot← Back to searchSign inGet full accessPlusTerveys Lääkärit Oy
OYDissolvedY-tunnus 0361675-9Malmin Asematie 6Medical specialists activities · NACE 8622Est. 197899 employees
Revenue 2024
EUR 11,5M
-13% vs 2023
EBITDA margin
0.0%
+101% vs 2023
Equity ratio
0.2%
Financial strength
Net profit 2024
EUR 592K
+356% vs 2023
| Revenue | EUR 11,5M | -13% |
| EBITDA | EUR 3K | +101% |
| Net profit | EUR 592K | +356% |
| Total assets | EUR 7,7M | +0% |
| Equity | EUR 17K | -98% |
| Employees | 99 | — |
Legal name
PlusTerveys Lääkärit Oy
Y-tunnus number
0361675-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
18. elokuuta 1978
Share capital
EUR 8 000
Employees
99 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on harjoittaa lääkäri- ja fysioterapiatoimintaa sekä muiden terveydenhuollon palveluiden ja näitä tukevien palveluiden tuottamista. Yhtiö voi harjoittaa myös psykoterapiatoimintaa. Yhtiö voi omistaa ja hallita vastaanottohuoneistoja, koneita ja välineitä sekä vuokrata vastaanottojen käyttöoikeuksia ja siihen liittyvän henkilökunnan palveluksia ja harjoittaa henkilövuokrausta. Yhtiö voi harjoittaa terveydenhoitoalan koneiden, välineiden ja tarveaineiden maahantuontia, välitystä ja kauppaa. Yhtiö voi harjoittaa toimintaa suoraan tai yhteistyössä muiden saman toimialan toimijoiden kanssa. Lisäksi yhtiö voi myös omistaa kiinteää omaisuuttaa, muiden yhtiöiden ja yhteisöjen osakkeita sekä harjoittaa arvopaperikauppaa.
Address
Malmin Asematie 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 21 951 | 16 520 | 23 265 | 13 209 | 11 525 |
| Staff expenses | −13 638 | −13 976 | −16 413 | −9 455 | −7 754 |
| EBITDA | 3 349 | −1 641 | 649 | −333 | 3 |
| Depreciation & amort. | −445 | −348 | −427 | −203 | −139 |
| EBIT | 2 904 | −1 989 | 222 | −536 | −136 |
| Net financials | 1 | 1 | −1 | 140 | 140 |
| Profit before tax | 642 | −1 923 | −951 | 130 | 592 |
| Tax | 594 | −0 | −0 | −0 | −0 |
| Net profit | 48 | −1 923 | 1 394 | 130 | 592 |
| Item | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 138 | 2 866 | 9 139 | 7 679 | 7 664 |
| Equity | 1 916 | −59 | 1 057 | 1 129 | 17 |
| Long-term debt | 81 | 74 | — | 0 | 0 |
| Short-term debt | 6 141 | 2 853 | 2 841 | 2 404 | 2 153 |
| Total debt | 6 222 | 2 927 | 2 841 | 2 404 | 2 153 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192024
Equity ratio
0.2%
This company
38.2%
Market median
-99% vs market
20192024
Return on equity
3441.9%
This company
18.4%
Market median
+18606% vs market
20192024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20192024
Asset turnover
1.50×
This company
1.12×
Market median
+34% vs market
20192024
Debt / equity
444.32×
This company
0.62×
Market median
-71565% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-01-01 – 2022-06-30
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (10) | ||
PJ Person with significant control | Person with significant control | 2021 |
KM Person with significant control | Person with significant control | 2022 |
PJ Person with significant control | Person with significant control | 2018 |
ME Person with significant control | Person with significant control | 2020 |
TM Chief Executive Officer | Chief Executive Officer | 2020 |
KM Person with significant control | Person with significant control | 2018 |
HC Person with significant control | Person with significant control | 2020 |
CM Person with significant control | Person with significant control | 2018 |
PM Person with significant control | Person with significant control | 2020 |
TT Person with significant control | Person with significant control | 2022 |
| Former (5) | ||
PA Person with significant control | Person with significant control | 2020 – 2022 |
RA | Audit | 2014 – 2023 |
KM Person with significant control | Person with significant control | 2018 – 2021 |
MT Person with significant control | Person with significant control | 2018 – 2020 |
EA Chief Executive Officer | Chief Executive Officer | 2007 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2023 | |
| Board of Directors | 2020 | |
| Chairperson | 2020 | |
| Former (7) | ||
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2018 – 2024 | |
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2018 – 2020 | |
| Chairperson | 2018 – 2020 | |
| Board of Directors | 2018 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PlusTerveys Oy | Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PlusTerveys Lääkärit Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pertti Juhani Patinen | Person with significant control | 0 companies |
| Kirsi Marja Anneli Saares | Person with significant control | 0 companies |
| Pirjo Anneli Savolainen | Person with significant control | 0 companies |
| Petri Juhani Hammar | Person with significant control | 0 companies |
| Mika Eerik Alho | Person with significant control | 0 companies |
| Tiina Marjaana Ristola | Chief Executive Officer | 0 companies |
| Kati Maria Niemelä | Person with significant control | 0 companies |
| Reeta Alina Virolainen | Audit | 0 companies |
| Kaj Mikael Wilhelm Karlsson | Person with significant control | 0 companies |
| Heidi Christina Mäkinen | Person with significant control | 0 companies |
| Carola Marianne Valkama | Person with significant control | 0 companies |
| Pia Maria Kittelä | Person with significant control | 0 companies |
| Miina Titta Maria Pulkkinen | Person with significant control | 0 companies |
| Eila Annikki Annala | Chief Executive Officer | 0 companies |
| Tero Tapio Tuominen | Person with significant control | 0 companies |
| Joni Raimo Mikael Aaltonen | Board of Directors | 0 companies |
| Kimmo Olavi Rauhala | Board of Directors | 0 companies |
| Pentti Ilmari Rytivaara | Board of Directors | 0 companies |
| Sirkku Saila Kaarina Meriläinen | Board of Directors | 0 companies |
| Antti-Jussi Juutinen | Board of Directors | 0 companies |
| Timo Ilmari Kauppila | Board of Directors | 0 companies |
| Henri Markus Kiviaho | Board of Directors | 0 companies |
| Kimmo Olavi Haahkola | Board of Directors | 0 companies |
| Tapio Lauri Terho Kannisto | Board of Directors | 0 companies |
| Matti Pentti Pöyry | Board of Directors | 0 companies |
| Marja-Liisa Eloranta | Chairperson | 0 companies |
| Tero Heikki Tapio Ellilä | Board of Directors | 0 companies |
| Ossi Mikael Pohjola | Chairperson | 0 companies |